Related Experiment Video
Updated: Oct 18, 2025

08:49
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
1.1K
Primary Graft Dysfunction in Heart Transplant Recipients-Risk Factors and Longitudinal Outcomes
Nicholas F Smith1, Sina Salehi Omran2, Michael V Genuardi3
1From the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Summary
Primary graft dysfunction (PGD) after heart transplantation occurred in 16.5% of patients. Prolonged ischemic time was linked to PGD, which significantly increased long-term mortality risks.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Significant variability existed in defining primary graft dysfunction (PGD) before the 33rd Annual International Society for Heart and Lung Transplantation conference.
- The incidence, risk factors, and outcomes of consensus-defined PGD require further investigation.
Purpose of the Study:
- To investigate the incidence, risk factors, and outcomes of consensus-defined primary graft dysfunction (PGD) in adult cardiac transplant recipients.
- To identify predictors of PGD and high immediate postoperative inotropic requirement.
Main Methods:
- Retrospective examination of 448 adult cardiac transplant recipients from 2005 to 2017.
- Comparison of patient and procedural characteristics between PGD cases and controls.
- Multivariable logistic regression to model PGD and high-inotrope requirement; longitudinal mortality follow-up.
Main Results:
- The incidence of PGD was 16.5%. No significant differences in baseline characteristics were observed between PGD and no-PGD groups.
- Each 10-minute increase in ischemic time was associated with a 5% greater odds of PGD (OR=1.05).
- PGD was associated with significantly higher 30-day, 1-year, and 5-year mortality rates compared to no PGD (45.8% vs 21.5% at 5 years).
Conclusions:
- Consensus-defined PGD is a significant predictor of increased long-term mortality after heart transplantation.
- Prolonged ischemic time is a modifiable risk factor for PGD.
- Findings have clinical implications for patient management and resource allocation under revised organ allocation systems.
Related Concept Videos
Kidney Transplant I: Introduction
82
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
82
Tissue Transplantation
606
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
606
Kidney Transplant II: Surgical Procedure
98
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
98

